An Open Label Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder

Condition:   Borderline Personality Disorder Intervention:   Drug: Brexpiprazole Sponsor:   Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials